What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
Ashwin N. Ananthakrishnan mostly deals with Ulcerative colitis, Inflammatory bowel disease, Internal medicine, Crohn's disease and Disease.
The Ulcerative colitis study combines topics in areas such as Vitamin D and neurology, Colitis, Immunology and Risk factor.
His research in Inflammatory bowel disease intersects with topics in Surgery, Environmental health, Confidence interval, Gold standard and Dysbiosis.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology.
The concepts of his Crohn's disease study are interwoven with issues in Odds ratio, Retrospective cohort study and Pneumonia.
His Disease study combines topics from a wide range of disciplines, such as Genetics, Logistic regression, Depression and Metronidazole.
His most cited work include:
- Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (3117 citations)
- Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections (1113 citations)
- Epidemiology and risk factors for IBD (637 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease.
His work on Disease, Prospective cohort study, Odds ratio and Cohort as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His Inflammatory bowel disease research is multidisciplinary, relying on both Clostridium difficile, Microbiome, Incidence and Intensive care medicine.
Ashwin N. Ananthakrishnan has included themes like Colitis and Immunology in his Ulcerative colitis study.
His biological study spans a wide range of topics, including Inflammatory Bowel Diseases, Vitamin D and neurology, Colorectal cancer and Confounding.
His work in Crohn's disease addresses issues such as Infliximab, which are connected to fields such as Adalimumab.
He most often published in these fields:
- Internal medicine (66.67%)
- Inflammatory bowel disease (38.35%)
- Ulcerative colitis (36.08%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (66.67%)
- Inflammatory bowel disease (38.35%)
- Ulcerative colitis (36.08%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Gastroenterology.
When carried out as part of a general Internal medicine research project, his work on Prospective cohort study, Odds ratio, Cohort and Vedolizumab is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His research on Inflammatory bowel disease concerns the broader Disease.
His studies deal with areas such as Microbiome, Adverse effect, Randomized controlled trial, Immunology and Retrospective cohort study as well as Ulcerative colitis.
In his study, Nurses' Health Study and Body mass index is strongly linked to Hazard ratio, which falls under the umbrella field of Crohn's disease.
As part of the same scientific family, Ashwin N. Ananthakrishnan usually focuses on Gastroenterology, concentrating on Inflammatory Bowel Diseases and intersecting with MEDLINE.
Between 2018 and 2021, his most popular works were:
- Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. (435 citations)
- ACG Clinical Guideline: Ulcerative Colitis in Adults (237 citations)
- Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis (236 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary areas of study are Ulcerative colitis, Inflammatory bowel disease, Internal medicine, Crohn's disease and Disease.
His Ulcerative colitis research integrates issues from Microbiome, Disease management and Infliximab.
His work carried out in the field of Inflammatory bowel disease brings together such families of science as Incidence, Inflammation, Immune system, Intensive care medicine and Prospective cohort study.
Internal medicine is closely attributed to Gastroenterology in his study.
His Crohn's disease research is multidisciplinary, incorporating elements of Food group, Adverse effect, Emergency department, Emergency medicine and Parenteral nutrition.
His Disease research includes elements of Gut flora, Immunology and Epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
